Roche (SIX: RO, ROG; OTCQX: RHHBY) received CE mark approval for its Elecsys ApoE4 test, the first in-vitro diagnostic immunoassay ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE